A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer

BACKGROUND: The clinical behavior of prostate cancer (PCa) is variable, and while the majority of cases remain indolent, 10% of patients progress to deadly forms of the disease. Current clinical predictors used at the time of diagnosis have limitations to accurately establish progression risk. Here...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Main Authors: Georgescu, Constantin, Corbin, Joshua M., Thibivilliers, Sandra, Webb, Zachary D., Zhao, Yan D., Koster, Jan, Fung, Kar-Ming, Asch, Adam S., Wren, Jonathan D., Ruiz-Echevarría, Maria J.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503380/
https://ncbi.nlm.nih.gov/pubmed/31060542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5592-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares